Computer vision to detect phenotypic signals, resulting in novel, pan-cancer biomarkers
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
114
NCT00977444
Evaluation of a New Formulation Useful for the Osteoarthrosis Treatment
Phase: Phase 2/3
Role: Lead Sponsor
Start: Nov 30, 2007
Completion: Oct 31, 2009